Athanor Capital’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-24,398
| Closed | -$624K | – | 946 |
|
|
2021
Q1 | $624K | Sell |
24,398
-17,799
| -42% | -$455K | 0.01% | 396 |
|
|
2020
Q4 | $930K | Sell |
42,197
-3,304
| -7% | -$72.8K | 0.02% | 293 |
|
|
2020
Q3 | $819K | Buy |
45,501
+37,619
| +477% | +$677K | 0.03% | 251 |
|
|
2020
Q2 | $200K | Buy |
+7,882
| New | +$200K | 0.01% | 487 |
|
|
2020
Q1 | – | Sell |
-24,350
| Closed | -$536K | – | 385 |
|
|
2019
Q4 | $536K | Buy |
+24,350
| New | +$536K | 0.02% | 204 |
|
|
2019
Q3 | – | Sell |
-14,800
| Closed | -$233K | – | 233 |
|
|
2019
Q2 | $233K | Buy |
+14,800
| New | +$233K | 0.03% | 114 |
|